|
Podiatry
Podiatry
The nail, the heel, and everything between.
Non-thermal, FDA-cleared laser therapy for the two complaints that fill a podiatry schedule — onychomycosis and plantar fasciitis — plus a handheld for the rest of the foot.
Erchonia holds the category’s only non-thermal clearances for both: Lunula, the first and only non-thermal laser FDA cleared to increase clear nail in onychomycosis, and the FX 635, the only low-level laser cleared for chronic heel pain from plantar fasciitis. Neither heats, neither hurts, neither needs a prescription pad — and both run inside the visits you already book.
- Lunula · onychomycosis
- FX 635 · plantar fasciitis
- Non-thermal
- No downtime
- Cash-pay services
Two clearances, one officeLunula for the nail (K153164) and the FX 635 for the heel (K180197) — the only non-thermal lasers cleared for either indication.
6.1 mm
of new clear nail growth at six months in Erchonia’s Lunula clinical trial
89%
of treated toenails grew clearer over six months — Zang et al., JCAD 2017
12 min
per Lunula session, all five toes at once — as few as four sessions
0
heat, pain, downtime or drug interactions on either platform
The line
Three lasers for the podiatry room.
A cleared answer for the nail, a cleared answer for the heel, and a handheld for the ankle, the forefoot and post-op.
Lunula
640 nm red + 405 nm violet · whole-foot chamber
The first and only non-thermal laser FDA cleared to increase clear nail in onychomycosis. Twelve-minute sessions, all five toes at once, no heat, no pain, no oral anti-fungals — and a rental program.
Best for: onychomycosis — a cash-pay service for the most common complaint in the waiting room.
FX 635
Stand-mounted scanner · hands-free
The only low-level laser FDA cleared for chronic heel pain arising from plantar fasciitis — on a double-blind, placebo-controlled trial. Three line-generating red diodes, hands-free, while you see the next patient.
Best for: plantar fasciitis and the chronic musculoskeletal foot pain that fills the schedule.
EVRL
405 nm violet + 635 nm red · handheld
Red and violet in one handheld — the everyday instrument for the ankle, the forefoot, post-surgical sites and the patient who needs treatment in the chair.
Best for: the rest of the foot: sprains, neuromas, post-op healing and pain protocols between the two cleared services.
Lunula results: 6.1 mm is Erchonia’s FDA clinical trial figure for K153164; 89% of nails improved and 67% reached ≥3 mm of new clear nail in Zang, Sullivan & Shanks, JCAD 2017 (mean 5.18 mm). Individual results vary.
Why podiatrists choose Erchonia
Cleared, drug-free, and cash-pay.
The economics of a podiatry laser are simple — the patients already have the condition.
01
Two indications no one else holds
Onychomycosis and plantar fasciitis are the podiatry office’s two most common presentations, and Erchonia holds the only non-thermal clearances for both. That is a treatment you can offer every patient, including the ones oral anti-fungals and injections exclude.
02
Minutes of staff time
Lunula runs itself for twelve minutes with the whole foot in the chamber; the FX 635 runs hands-free on its stand. Both fit inside the visit you already booked and neither consumes a provider.
03
No heat, so no sell
Thermal nail lasers hurt and thermal heel treatments need cooldown. Non-thermal means the patient feels nothing, walks out immediately, and comes back for the next session without persuasion.
Next step
Put both clearances in your office.
Tell us how your practice runs and we’ll walk you through Lunula, the FX 635 and the rental options — or start with a 1:1 demo.
Also see the Medical & Integrative industry page. Prescription use (21 CFR 801 Subpart D).